---
title: Metoclopramide
aliases: ['Maxolon']
date: "2025-10-23"
updated: "2025-10-23"
sources: ["BNF", "MIMS", "MHRA"]
---

<Alert>
Dopamine D₂ receptor antagonist.
Enhances gastric emptying and reduces nausea and vomiting.
Acts on the chemoreceptor trigger zone and GI tract.
</Alert>

---

## Indication

- Nausea and vomiting (including migraine-related)
- Gastroesophageal reflux disease (GERD)
- Diabetic gastroparesis
- Postoperative nausea and vomiting
- Nausea due to chemotherapy or radiotherapy

---

## Dose

### Adults

<Table>
  <TableHeader>
    <TableRow>
      <TableHead>Form</TableHead>
      <TableHead>Dose</TableHead>
      <TableHead>Max Daily Dose</TableHead>
    </TableRow>
  </TableHeader>
  <TableBody>
    <TableRow>
      <TableCell>Tablet / Oral</TableCell>
      <TableCell>10 mg up to 3 times daily before meals</TableCell>
      <TableCell>30 mg</TableCell>
    </TableRow>
    <TableRow>
      <TableCell>IM / IV injection</TableCell>
      <TableCell>10 mg every 8 hours as needed</TableCell>
      <TableCell>30 mg</TableCell>
    </TableRow>
  </TableBody>
</Table>

### Children (over 1 year)

- 0.1–0.15 mg/kg (max 10 mg per dose)
- Up to 3 times daily
- **Use only for short-term (≤5 days)** under medical advice

---

## Administration

- Take 15–30 minutes before meals.
- For IV: give slowly over ≥3 minutes to reduce side effects.
- Avoid prolonged use to reduce risk of neurological adverse effects.

---

## Contraindications

- Hypersensitivity to metoclopramide
- Gastrointestinal bleeding, obstruction, or perforation
- History of tardive dyskinesia or epilepsy
- Pheochromocytoma
- Use with levodopa or dopamine agonists

---

## Adverse Reactions

- **Common**
  - Drowsiness, restlessness
  - Fatigue, diarrhoea

- **Serious / Rare**
  - Extrapyramidal symptoms (involuntary movements, dystonia)
  - Tardive dyskinesia (especially with prolonged use)
  - Hyperprolactinaemia (breast symptoms)
  - Neuroleptic malignant syndrome (very rare)

---

## Pregnancy and Lactation

<Callout>
**Pregnancy:**
Generally considered safe for short-term use (e.g., hyperemesis gravidarum).
Use lowest effective dose.

**Lactation:**
Passes into breast milk in small amounts.
Usually safe but monitor infant for sedation or irritability.
</Callout>

---

## Warnings

- Limit use to **maximum 5 days**.
- Avoid in children less 1 year due to high risk of extrapyramidal reactions.
- Caution in elderly and patients with renal impairment.
- Do not use with other dopamine antagonists or serotonergic drugs unless necessary.
